Literature DB >> 8262308

Delayed onset of insulin activation of the insulin receptor kinase in vivo in human skeletal muscle.

G R Freidenberg1, S Suter, R R Henry, J Nolan, D Reichart, J M Olefsky.   

Abstract

During the infusion of insulin in vivo, the rate of activation of glucose disposal lags significantly behind the rate of increase in serum insulin levels. To determine whether this delay was related to transcapillary transport of insulin, we determined increments in serum insulin levels, glucose disposal rates (GDR), and insulin receptor (IR) kinase activity measured during continuous infusions of insulin (40 and 120 mU.m-2.min-1) administered to 8 nondiabetic males; similar studies were done at 1,200.m-2.min-1 in 2 of the subjects. Half-maximal insulin levels were achieved at a mean of 4.9 and 7.2 min during the 40 and 120 mU.m-2.min-1 clamps, respectively, with corresponding half-maximal GDR stimulation at a mean of 59 and 47 min. Unlike the rise in insulin levels, IR kinase activation was much slower with half-maximal activity occurring at approximately 40-60 min in the 2 clamps. Thus, the rise in serum insulin levels in each clamp was much faster than the increment in either kinase activity or glucose disposal. Insulin infusion increased both IR kinase and GDR maximally approximately 10-fold, with half-maximal stimulation at approximately 3,600 and approximately 700 pM, indicating spare kinase for glucose disposal. These results demonstrate that the delay in stimulation of glucose disposal by insulin is related to a rate-limiting step between the intravascular space and the cell-surface of skeletal muscle. This may involve delayed transendothelial transport of insulin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8262308     DOI: 10.2337/diab.43.1.118

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

1.  Insulin entry into muscle involves a saturable process in the vascular endothelium.

Authors:  S Majumdar; A J Genders; A C Inyard; V Frison; E J Barrett
Journal:  Diabetologia       Date:  2011-10-15       Impact factor: 10.122

2.  Transendothelial movement of adiponectin is restricted by glucocorticoids.

Authors:  Thanh Q Dang; Nanyoung Yoon; Helen Chasiotis; Emily C Dunford; Qilong Feng; Pingnian He; Michael C Riddell; Scott P Kelly; Gary Sweeney
Journal:  J Endocrinol       Date:  2017-08       Impact factor: 4.286

Review 3.  The barrier within: endothelial transport of hormones.

Authors:  Cathryn M Kolka; Richard N Bergman
Journal:  Physiology (Bethesda)       Date:  2012-08

Review 4.  Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature.

Authors:  Eugene J Barrett; Hong Wang; Charles T Upchurch; Zhenqi Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-24       Impact factor: 4.310

5.  The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues.

Authors:  D Turk; A Alzaid; S Dinneen; K S Nair; R Rizza
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

6.  Mechanisms of insulin resistance in experimental hyperinsulinemic dogs.

Authors:  P D Miles; S Li; M Hart; O Romeo; J Cheng; A Cohen; K Raafat; A R Moossa; J M Olefsky
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

Review 7.  The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action.

Authors:  E J Barrett; E M Eggleston; A C Inyard; H Wang; G Li; W Chai; Z Liu
Journal:  Diabetologia       Date:  2009-03-13       Impact factor: 10.122

Review 8.  Altered transendothelial transport of hormones as a contributor to diabetes.

Authors:  Nanyoung Yoon; Thanh Q Dang; Helen Chasiotis; Scott P Kelly; Gary Sweeney
Journal:  Diabetes Metab J       Date:  2014-04       Impact factor: 5.376

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.